|
|
Article: Cephalon Announces Modafinil Receives Marketing Approval in Mexico.
- Article from:
- PR Newswire
- Article date:
- January 22, 2002
CopyrightCOPYRIGHT 2002 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
WEST CHESTER, Pa. -- Cephalon, Inc. , an international biopharmaceutical company, announced today that its partner, Armstrong Laboratorios de Mexico S.A.C.V., has received approval to sell and distribute modafinil in Mexico. Armstrong will market modafinil under the brand name, MODIODAL. Cephalon controls worldwide rights to modafinil, marketed as PROVIGIL(R) (modafinil) tablets [C- IV] in the United States and several other countries.
PROVIGIL is a unique, wake-promoting agent currently approved in several countries for the treatment of excessive daytime sleepiness associated with narcolepsy. The most common side effects associated with PROVIGIL in clinical ...